E-ISSN 2149-388X | ISSN 2149-0430
 
2024, Vol: 10, Issue: 2
10 / 2Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Cover Letter
License Agreement
Title Page

Original Article 


The Epidemiology of Hyperprolactinemia in A Single Tertiary Care Center: The Importance of Drug History and Role of An Endocrinologist

Mahmut Bakir Koyuncu, Kerem Sezer, Gulhan Orekeci Temel.


Abstract
Introduction: The underlying causes of hyperprolactinemia differ between studies. The study aimed to determine the causes, initial signs, and treatment methods of hyperprolactinemia.
Materials and Methods: Prolactin (PRL) measurement was requested from 16241 patients between January 2016
and December 2019. A total of 176 patients whose serum prolactin levels above 29.9 ng/mL in two consecutive measurements were included in this study. Electronic Health Records (EHR) of these patients were reviewed.
Results: Forty-Seven (26.8%) of 176 patients had a prolactinoma. Among the prolactinoma group, 63.8% of the patients had microadenoma. Polycystic Ovary Syndrome (PCOS)(29.5%), drugs (20.9%), and pituitary disorders other than prolactinoma (13.2%) were the most common causes of hyperprolactinemia in the non-prolactinoma group. Galactorrhea (38.3%) was the most common initial sign. Cabergoline's starting dose in the Endocrinology clinic was 1 mg/week, and 87.2% of the cases started with a 1 mg/week dose. All of the other cases (12.8%) who were diagnosed by other departments received inappropriate doses of cabergoline.
Conclusions: Drug-induced hyperprolactinemia may be much more common than previously thought. Referring these patients to the Endocrinology clinic will be much more beneficial to determine both the correct dosage of cabergoline and the cause of hyperprolactinemia.

Key words: Hyperprolactinemia, prolactinoma, cabergoline


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Mahmut Bakir Koyuncu
Articles by Kerem Sezer
Articles by Gulhan Orekeci Temel
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Koyuncu MB, Sezer K, Temel GO. The Epidemiology of Hyperprolactinemia in A Single Tertiary Care Center: The Importance of Drug History and Role of An Endocrinologist. Ulutas Med J. 2021; 7(2): 92-98. doi:10.5455/umj.20210325075502

Web Style

Koyuncu MB, Sezer K, Temel GO. The Epidemiology of Hyperprolactinemia in A Single Tertiary Care Center: The Importance of Drug History and Role of An Endocrinologist. https://www.ulutasmedicaljournal.com/?mno=67749 [Access: March 06, 2024]. doi:10.5455/umj.20210325075502

AMA (American Medical Association) Style

Koyuncu MB, Sezer K, Temel GO. The Epidemiology of Hyperprolactinemia in A Single Tertiary Care Center: The Importance of Drug History and Role of An Endocrinologist. Ulutas Med J. 2021; 7(2): 92-98. doi:10.5455/umj.20210325075502


Vancouver/ICMJE Style

Koyuncu MB, Sezer K, Temel GO. The Epidemiology of Hyperprolactinemia in A Single Tertiary Care Center: The Importance of Drug History and Role of An Endocrinologist. Ulutas Med J. (2021), [cited March 06, 2024]; 7(2): 92-98. doi:10.5455/umj.20210325075502


Harvard Style

Koyuncu, M. B., Sezer, . K. & Temel, . G. O. (2021) The Epidemiology of Hyperprolactinemia in A Single Tertiary Care Center: The Importance of Drug History and Role of An Endocrinologist. Ulutas Med J, 7 (2), 92-98. doi:10.5455/umj.20210325075502


Turabian Style

Koyuncu, Mahmut Bakir, Kerem Sezer, and Gulhan Orekeci Temel. 2021. The Epidemiology of Hyperprolactinemia in A Single Tertiary Care Center: The Importance of Drug History and Role of An Endocrinologist. THE ULUTAS MEDICAL JOURNAL, 7 (2), 92-98. doi:10.5455/umj.20210325075502


Chicago Style

Koyuncu, Mahmut Bakir, Kerem Sezer, and Gulhan Orekeci Temel. "The Epidemiology of Hyperprolactinemia in A Single Tertiary Care Center: The Importance of Drug History and Role of An Endocrinologist." THE ULUTAS MEDICAL JOURNAL 7 (2021), 92-98. doi:10.5455/umj.20210325075502


MLA (The Modern Language Association) Style

Koyuncu, Mahmut Bakir, Kerem Sezer, and Gulhan Orekeci Temel. "The Epidemiology of Hyperprolactinemia in A Single Tertiary Care Center: The Importance of Drug History and Role of An Endocrinologist." THE ULUTAS MEDICAL JOURNAL 7.2 (2021), 92-98. Print. doi:10.5455/umj.20210325075502


APA (American Psychological Association) Style

Koyuncu, M. B., Sezer, . K. & Temel, . G. O. (2021) The Epidemiology of Hyperprolactinemia in A Single Tertiary Care Center: The Importance of Drug History and Role of An Endocrinologist. THE ULUTAS MEDICAL JOURNAL, 7 (2), 92-98. doi:10.5455/umj.20210325075502


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About THE ULUTAS MEDICAL JOURNAL

The Ulutas Medical Journal (UMJ) is a 3 monthly (quarterly), open access, double-blind peer-reviewed, an international journal. Writin ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Journal Owner
HAYRİYE ZEHRA ULUTAŞ
Phone: +90 (532) 165 96 39​
E-mail: zehrakenanoglu@hotmail.com​
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Editor-In-Chief
KEMAL TURKER ULUTAS, MD, Assc. Prof.
Phone: + 90 (555) 491 35 59​
E-mail: drkemalturker@gmail.com
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Publisher Information
SCOPEMED Publishing Co. - TURKEY​
E-mail: scopemed@scopemed.org
Web: https://www.scopemed.com/

 

We welcome your submissions, suggestions, comments, or questions. To reach us, please use one of the methods provided on this page or Email us at ulutasmedicaljournal@gmail.com​

We will respond within 48 to 72 hours.